Coronary Artery Disease Clinical Trials in Washington D.C., District of Columbia

5 studies are recruiting for coronary artery disease in Washington D.C., District of Columbia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Product Surveillance Registry

   The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

   Stage

   Not phased

   Ages

   Any age

   Site

   Research site, Washington D.C., District of Columbia

   Locations

   401 in total

   Run by

   Medtronic

   See if you can join NCT01524276 on ClinicalTrials.gov

2. Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

   The objective of this study is to assess the safety and efficacy of the Freesolve resorbable magnesium scaffold (RMS) in the treatment of subjects with up to two de novo lesions in native coronary arteries compared to the Xience coronary drug-eluting stent (DES) system

   Stage

   Not phased

   Ages

   18 to 80

   Site

   MedStar Washington Hospital Center, Washington D.C., District of Columbia

   Locations

   3 in total

   Run by

   Teleflex

   See if you can join NCT07258290 on ClinicalTrials.gov

3. SELUTION 4 De Novo Small Vessel IDE Trial

   Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…

   Stage

   Not phased

   Ages

   18 and older

   Site

   MedStar Washington Hospital Center, Washington D.C., District of Columbia

   Locations

   70 in total

   Run by

   M.A. Med Alliance S.A.

   See if you can join NCT05946629 on ClinicalTrials.gov

4. Prevail Global Study

   The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Medstar Washington Hospital Center, Washington D.C., District of Columbia

   Locations

   51 in total

   Run by

   Medtronic Vascular

   See if you can join NCT06535854 on ClinicalTrials.gov

5. Prevent Cardiac Surgery Associated AKI Trial

   Prevent CSA-AKI (Cardiac Surgery Associated Acute Kidney Injury) trial is a double blinded randomized controlled trial, 242 patients undergoing elective cardiopulmonary bypass surgery (CPB)will either receive a placebo or daily 1200 mg of Co enzyme Q10 (CoQ10) and 1000 mg of Glutathione (GSH), the …

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   George Washington University Hospital, Washington D.C., District of Columbia

   Run by

   George Washington University

   See if you can join NCT06620523 on ClinicalTrials.gov